MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Returns | |||||
| Return on Equity | 61.3% | 44.9% | -24.1% | -23.6% | |
| Return on Assets | -58.0% | -38.7% | -23.1% | -22.6% | |
| Return on Inv Capital | 47.8% | 38.5% | -20.9% | -21.0% | |
| Liquidity | |||||
| Current Ratio | 12.89x | 21.26x | 24.19x | 24.62x | |
| Quick Ratio | 12.89x | 21.26x | 24.19x | 24.62x | |
| Cash Ratio | 7.06x | 7.77x | 4.47x | 4.86x | |
| Leverage | |||||
| Debt / Equity | -0.01x | -0.00x | 0.00x | 0.00x | |
| Interest Coverage | -68.88x | -- | -- | -- | |
| Equity Multiplier | -1.06x | -1.16x | 1.04x | 1.04x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | 0.88x | 0.98x | 0.88x | 0.92x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--